Johnson & Johnson (JNJ) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Johnson & Johnson (JNJ) is Neutral.

The composite score behind that read is +0.18, weighing +0.35 of bullish evidence against -0.32 bearish.

Johnson & Johnson last closed at $261.44, +1.93% on the session.

Against the IVW growth benchmark the position is +1.13% over the forecast window.

The read is built from 15 underlying insights — 9 bullish and 6 bearish.

Agreement across those insights is 60%.

Johnson & Johnson has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Johnson & Johnson in the 29th percentile on valuation and the 85th percentile on return on equity, where 100 is best.

Johnson & Johnson is classified under Health Care / Pharmaceuticals, with a market capitalisation of $618.09B.

StockMap tracks Johnson & Johnson as the 2nd largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Johnson & Johnson ranks 17th of 151 in the group, against a group median of -0.08.